Apria, Inc.
Industry
- Services
- Medical Devices
Other Names/Subsidiaries
- Apria Healthcare Group Inc.
See more in Biomedtracker
Latest on Apria, Inc.
In Vivo
Device Transactions Thirty-six financings brought in $1.2 billion during 2013’s fourth quarter, almost double Q3’s $644 million total, making it the most lucrative quarter of 2013. The majority (63%)
In Vivo
Exhibit 1 Top Alliances In November 2013 (Potential Deal Value In $M*) *Potential deal value is the sum of up-front fees plus pre-commercialization money. Strategic Transactions Exhibit 2 Top Mergers
Scrip
• By Mary Stuart
When patients comply with their drug regimens, everyone benefits; patients, pharmaceutical companies and payers The behavior of patients between doctor visits has been one of the most unmanageable com